Canna Law Blog

OCTOBER 12, 2022

Based upon it’s “scientific and medical evaluation”, the FDA found marijuana supremely dangerous and formally recommended that the plant remain in schedule I. Fundamentally, however, things are no different than in 2015. First, HHS and FDA undertook this very review, to less fanfare, only seven years ago.

Legislation 84

Legislation Decriminalization Medical Evaluation Cannabis 84

Cannabis Law Report

JANUARY 30, 2019

Senator Feinstein and I wrote to DOJ and Health and Human Services (HHS) on two occasions requesting that a scientific and medical evaluation of CBD be conducted. The first letter was sent on May 13, 2015, and the second letter was sent on November 18, 2018. What is the status of this request?

Research and Development 63

Research and Development DEA CBD Law 63

Canna Law Blog

AUGUST 31, 2023

We haven’t yet seen the HHS letter so we’re not sure what changed from the last “medical and scientific” evaluation undertaken by the Food and Drug Administration (FDA) and HHS in 2015 , but hey, we’ll take it.

DEA 116

DEA Marijuana Banking Research and Development 116

Cannabis Law Report

MARCH 25, 2019

The Attorney General forwards the request to the Health and Human Services Secretary and requests a scientific and medical evaluation and recommendation, as specified by 23 USC 811(b-c). ii] See How to reschedule marijuana, and why it’s unlikely anytime soon , The Brookings Institution [2015]. 1] professionals. 1] professionals.

Banking 45

Banking Law Marijuana State Laws 45